Valerio Gristina/X
Mar 28, 2025, 00:33
Valerio Gristina: Umberto Malapelle on biomarker detection and treatment impact: CGP vs. single-gene testing in lung cancer
Valerio Gristina, Medical Doctor Phd at the University of Palermo, shared a post on X:
“Brilliant take of Umberto Malapelle on biomarker detection rates, treatment impact, and adoption across Europe using CGP vs. single-gene testing in lung cancer.
Precision oncology starts with diagnostic accuracy and timely testing.”
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, shared the post by Valerio Gristina, adding:
“Congrats, Umberto Malapelle.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:35
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13